Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md 20892-1876.
New England Journal of Medicine (Impact Factor: 55.87). 02/1995; 332(4):209-16. DOI: 10.1056/NEJM199501263320402
Source: PubMed


In a small percentage of persons infected with human immunodeficiency virus type 1 (HIV-1), there is no progression of disease and CD4+ T-cell counts remain stable for many years. Studies of the histopathological, virologic, and immunologic characteristics of these persons may provide insight into the pathogenic mechanisms that lead to HIV disease and the protective mechanisms that prevent progression to overt disease.
We studied 15 subjects with long-term nonprogressive HIV infection and 18 subjects with progressive HIV disease. Nonprogressive infection was defined as seven or more years of documented HIV infection, with more than 600 CD4+ T cells per cubic millimeter, no antiretroviral therapy, and no HIV-related disease. Lymph nodes from the subjects with nonprogressive infection had significantly fewer of the hyperplastic features, and none of the involuted features, characteristic of nodes from subjects with progressive disease. Plasma levels of HIV-1 RNA and the viral burden in peripheral-blood mononuclear cells were both significantly lower in the subjects with nonprogressive infection than in those with progressive disease (P = 0.003 and P = 0.015, respectively). HIV could not be isolated from the plasma of the former, who also had significantly higher titers of neutralizing antibodies than the latter. There was viral replication, however, in the subjects with nonprogressive infection, and virus was consistently cultured from mononuclear cells from the lymph nodes. In the lymph nodes virus "trapping" varied with the degree of formation of germinal centers, and few cells expressing virus were found by in situ hybridization. HIV-specific cytotoxic activity was detected in all seven subjects with nonprogressive infection who were tested.
In persons who remain free of disease for many years despite HIV infection the viral load is low, but viral replication persists. Lymph-node architecture and immune function appear to remain intact.

Download full-text


Available from: Cecilia Graziosi, Aug 05, 2015
  • Source
    • "HIV-1-infected individuals who remain asymptomatic despite prolonged infection are designated as long-term non-progressors (LTNP). These individuals frequently have vigorous anti-HIV-1 immune responses detectable with the IFN-γElispot assay or intracellular IFN-γ staining [20], [21]. When the HIV-1 sequences of LTNP were examined, A-to-G and G-to-A hyper-mutations were found throughout the entire genome, suggesting a role for RNA editing enzymes in viral replication [22], [23]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: While exploring the effects of aerosol IFN-γ treatment in HIV-1/tuberculosis co-infected patients, we observed A to G mutations in HIV-1 envelope sequences derived from bronchoalveolar lavage (BAL) of aerosol IFN-γ-treated patients and induction of adenosine deaminase acting on RNA 1 (ADAR1) in the BAL cells. IFN-γ induced ADAR1 expression in monocyte-derived macrophages (MDM) but not T cells. ADAR1 siRNA knockdown induced HIV-1 expression in BAL cells of four HIV-1 infected patients on antiretroviral therapy. Similar results were obtained in MDM that were HIV-1 infected in vitro. Over-expression of ADAR1 in transformed macrophages inhibited HIV-1 viral replication but not viral transcription measured by nuclear run-on, suggesting that ADAR1 acts post-transcriptionally. The A to G hyper-mutation pattern observed in ADAR1 over-expressing cells in vitro was similar to that found in the lungs of HIV-1 infected patients treated with aerosol IFN-γ suggesting the model accurately represented alveolar macrophages. Together, these results indicate that ADAR1 restricts HIV-1 replication post-transcriptionally in macrophages harboring HIV-1 provirus. ADAR1 may therefore contribute to viral latency in macrophages.
    Full-text · Article · Aug 2014 · PLoS ONE
  • Source
    • "From a clinical standpoint, during the first years of the epidemic, it became soon clear that consistent clinical variability could be observed among patients even in the absence of successful treatment. A benign disease course in otherwise untreated patients was identified through the observation of HIV-infected patients with long-term non-progressing disease (i.e., high CD4+ T cells >450/μl and low level viremia, LTNP) and of patients with high CD4+ T-lymphocytes and undetectable viremia (elite controller, EC) (77, 78). In addition, upon progressive disease with decreasing CD4+ cell counts, diverging courses are observed. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Natural killer (NK) cell function is regulated by a balance between the triggering of activating and inhibitory receptors expressed on their surface. A relevant effort has been focused so far on the study of KIR carriage/expression setting the basis for NK cell education and self-tolerance. Focus on the evolution and regulation of activating NK receptors has lagged behind so far. Our understanding of activating receptor expression and regulation has recently improved by evidences derived from in vitro and in vivo studies. Virus infection - either acute or chronic - determines preferential expansion of NK cells with specific phenotype, activating receptors, and with recall-like functional activity. Studies on patients with viral infection (HIV and HCV) and specific diverging clinical courses confirm that inter-individual differences may exist in baseline expression of natural cytotoxicity receptors (NKp46 and NKp30). The findings that patients with divergent clinical courses have different kinetics of activating receptor density expression upon NK cell activation in vitro provide an additional, time-dependent, functional parameter. Kinetic changes in receptor expression thus represent an additional parameter to basal receptor density expression. Different expression and inducibilities of activating receptors on NK cells contribute to the high diversity of NK cell populations and may help our understanding of the inter-individual differences in innate responses that underlie divergent disease courses.
    Full-text · Article · Jul 2014 · Frontiers in Immunology
  • Source
    • "Variability in susceptibility to HIV infection and in HIV disease progression highlights the influence of host factors in HIV pathogenesis [Lama and Planelles, 2007; Simm, 2007; Brass et al., 2008]. One example is the resistance to viral replication and slow progression to AIDS observed in 2–5% of infected individuals [Pantaleo et al., 1995; Deeks and Walker, 2007]. Long-term non-progressors (LTNP) are characterized by a relatively low viral load (<10,000 copies/mm 3 plasma), a low level of proviral DNA in peripheral blood mononuclear cells, and maintenance of a stable CD4 þ T-cell concentration (!400/mm 3 ) in the absence of antiretroviral treatment for at least 7 years. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Large variation exists in susceptibility to infection with Human Immunodeficiency Virus Type 1 (HIV), and disease progression. These observations demonstrate a role for antiretroviral host factors. Several reports describe α1-antitrypsin (A1AT), the most abundant circulating serine protease inhibitor, as a potent suppressor of HIV infection and replication. We identified the normal (M) and most common deficiency-associated (S and Z) isoforms of the A1AT gene in patients infected with HIV from four multicenter cohorts. The level of disease progression in the patients was characterized and the patients were grouped into as elite controllers (EC), long-term non-progressors (LTNP), or progressors (Prog). No significant difference in the distribution of A1AT alleles was observed in the EC, LTNP, or Prog groups. However, significantly increased prevalence of the A1AT deficiency-associated S allele was observed in HIV-infected patients compared to the prevalence of S A1AT in the general population. These results suggest that deficiency in A1AT may be a risk factor for acquisition of HIV infection, but physiological A1AT concentrations do not affect disease progression after infection occurs. J. Med. Virol. © 2013 Wiley Periodicals, Inc.
    Full-text · Article · Jan 2014 · Journal of Medical Virology
Show more